Published in Anaesthesia on January 01, 1994
Anaphylactoid reaction to syntocinon? Anaesthesia (1994) 0.94
Bronchospasm and laryngeal stridor as an adverse effect of oxytocin treatment. Crit Care (2003) 0.78
Oxytocin: an unexpected risk for cardiologic and broncho-obstructive effects, and allergic reactions in susceptible delivering women. Multidiscip Respir Med (2013) 0.76
An overdose of ecstasy. A role for dantrolene. Anaesthesia (1992) 4.57
Efficacy of physical conditioning exercise in patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum (1989) 2.22
DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J Biol Chem (1998) 2.10
Cardiovascular responses in black and white males during exercise. J Appl Physiol (1985) (1993) 2.06
Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis. J Infect Dis (1992) 1.64
Relationship of head circumference to measures of school performance. Clin Pediatr (Phila) (1990) 1.62
Expression of antigen-specific, major histocompatibility complex-restricted receptors by cortical and medullary thymocytes in situ. Cell (1985) 1.57
Elevated hemidiaphragm after cardiac operations: incidence, prognosis, and relationship to the use of topical ice slush. Ann Thorac Surg (1989) 1.53
The nucleotide sequence of the B gene of bacteriophage Mu. Nucleic Acids Res (1984) 1.51
Epithelial heterogeneity in the murine thymus: fucose-specific lectins bind medullary epithelial cells. J Immunol (1985) 1.49
Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP. J Nucl Med (1990) 1.47
Human cellular src gene: nucleotide sequence and derived amino acid sequence of the region coding for the carboxy-terminal two-thirds of pp60c-src. Mol Cell Biol (1985) 1.46
DNA sequence encoding the amino-terminal region of the human c-src protein: implications of sequence divergence among src-type kinase oncogenes. Mol Cell Biol (1987) 1.41
The Ly-49D receptor activates murine natural killer cells. J Exp Med (1996) 1.39
Drug syringe labelling--does complacency come with age? Anaesthesia (2003) 1.39
Subcutaneous morphine in children: taking the sting out of postoperative analgesia. Anaesthesia (1989) 1.38
Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res (1989) 1.37
Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2) J Exp Med (1995) 1.35
Identification of bidirectional promoters in the human KIR genes. Genes Immun (2007) 1.25
Isolation and structural mapping of a human c-src gene homologous to the transforming gene (v-src) of Rous sarcoma virus. J Virol (1985) 1.20
A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding. Endocr Relat Cancer (2005) 1.18
The value of the physical examination in the diagnosis of anemia. Correlation of the physical findings and the hemoglobin concentration. Arch Intern Med (1988) 1.18
Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J Immunol (2001) 1.15
Identification of distal KIR promoters and transcripts. Genes Immun (2006) 1.09
Radiolabeled antibody targeting of the HER-2/neu oncoprotein. Cancer Res (1992) 1.08
Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J Leukoc Biol (1999) 1.08
Role of a STAT binding site in the regulation of the human perforin promoter. J Immunol (1999) 1.07
Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J Immunol (1998) 1.06
Pain management in rheumatoid arthritis patients. A cognitive-behavioral approach. Arthritis Rheum (1988) 1.05
Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes Immun (2008) 1.00
RS cyclophilins: identification of an NK-TR1-related cyclophilin. Gene (1996) 0.99
Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1. J Pathol (2007) 0.98
Thymic vasculature: organizer of the medullary epithelial compartment? Int Immunol (2000) 0.98
Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun (2005) 0.97
Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium. Kidney Int (2001) 0.95
Medullary epithelial cell lines from murine thymus constitutively secrete IL-1 and hematopoietic growth factors and express class II antigens in response to recombinant interferon-gamma. Cell Immunol (1989) 0.95
The N-terminal cyclophilin-homologous domain of a 150-kilodalton tumor recognition molecule exhibits both peptidylprolyl cis-trans-isomerase and chaperone activities. Biochemistry (1994) 0.94
Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin Immunol Immunopathol (1989) 0.93
Intracellular catabolism of radiolabeled anti-CD3 antibodies by leukemic T cells. Cell Immunol (1991) 0.92
Inhibition of catabolism of radiolabeled antibodies by tumor cells using lysosomotropic amines and carboxylic ionophores. Cancer Res (1990) 0.92
Response of canine mast cell tumors to treatment with oral prednisone. J Vet Intern Med (1995) 0.91
Biochemical and morphological differences between fibroblasts and myoblasts from embryonic chicken skeletal muscle. Cell Tissue Res (1988) 0.90
Intracellular catabolism of radiolabeled anti-mu antibodies by malignant B-cells. Cancer Res (1992) 0.90
Cellular ras gene activity is required for full neoplastic transformation by polyomavirus. J Virol (1991) 0.90
Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. J Immunol (1997) 0.89
Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients. Arthritis Rheum (1991) 0.87
Psychological screening in rheumatoid arthritis. J Rheumatol (1990) 0.87
Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors. J Immunol (1999) 0.86
Cloning and characterization of a novel activating Ly49 closely related to Ly49A. J Immunol (1999) 0.86
Effects of halothane on motor evoked potential recorded in the extradural space. Br J Anaesth (1989) 0.85
Morphf mutants of Rous sarcoma virus: nucleotide sequencing analysis suggests that a class of morphf mutants was generated through splicing of a cryptic intron. J Virol (1987) 0.85
Expression of the NK-TR gene is required for NK-like activity in human T cells. J Immunol (1994) 0.85
Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins. J Leukoc Biol (2000) 0.85
Antigenic domains on the U1 small nuclear ribonucleoprotein-associated 70K polypeptide: a comparison of regions selectively recognized by human and mouse autoantibodies and by monoclonal antibodies. Clin Immunol Immunopathol (1991) 0.85
The use of cytokine and C-reactive protein measurements in cerebrospinal fluid during acute infective meningitis. Ann Clin Biochem (1994) 0.85
Spontaneous coping strategies to manage acute pain and anxiety during electrodiagnostic studies. Arch Phys Med Rehabil (1992) 0.84
Statistical analyses for research in arthritis when assessing change. Arthritis Care Res (1992) 0.84
Comparison of a computer tutorial with other methods for teaching well-newborn care. Am J Dis Child (1991) 0.83
Identification of a KIR antisense lncRNA expressed by progenitor cells. Genes Immun (2013) 0.83
In situ ultrastructural demonstration of cells bearing Ia antigens in the murine pancreas. Diabetes (1985) 0.83
The murine Ly49 family: form and function. Arch Immunol Ther Exp (Warsz) (2001) 0.83
Molecular cloning and characterization of a novel mouse macrophage gene that encodes a nuclear protein comprising polyglutamine repeats and interspersing histidines. J Biol Chem (1996) 0.83
Use of the laryngeal mask airway in neonatal resuscitation. Anaesthesia (1993) 0.83
Pain control and rational thinking. Implications for rheumatoid arthritis. Arthritis Rheum (1989) 0.83
Sensory loss of the distal phalanx caused by pulse oximeter probe. Anaesthesia (1997) 0.82
Modification of gap junctions in cells transformed by a temperature-sensitive mutant of Rous sarcoma virus. J Membr Biol (1986) 0.81
The aortic intima in organ culture. Response to culture conditions and partial endothelial denudation. Am J Pathol (1988) 0.80
Comparison of capillary zone and immunosubtraction with agarose gel and immunofixation electrophoresis for detecting and identifying monoclonal gammopathies. Am J Clin Pathol (1999) 0.80
Characterization of the Ly49I promoter. Immunogenetics (2000) 0.80
Isolation of murine thymic epithelium and an improved method for its propagation in vitro. Anat Rec (1986) 0.79
Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Results of a 12-year longitudinal study. Ophthalmology (1993) 0.79
Phenotypic and functional characterization of a panel of cytotoxic murine NK cell clones that are heterogeneous in their enhancement of Ig secretion in vitro. Int Immunol (1998) 0.78
Relationship of self-efficacy to pain behavior. J Rheumatol (1991) 0.78
Intra-aortic balloon cardiac assist: complication rates for the surgical and percutaneous insertion techniques. Am Surg (1988) 0.78
Cisternal cerebrospinal fluid concentrations of morphine following intrathecal and epidural administration in the baboon. Anaesth Intensive Care (1987) 0.78
Biopsychosocial parameters of disease activity in rheumatoid arthritis. Arthritis Care Res (1991) 0.78
Characterization of the mouse Nktr gene and promoter. Genomics (1997) 0.78
Expression of class II MHC antigens in murine pancreas after streptozocin-induced insulitis. Diabetes (1988) 0.78
Expression of Ia antigens by murine kidney epithelium after exposure to streptozotocin. Am J Pathol (1987) 0.78
Ly49 gene expression in different inbred mouse strains. Immunol Res (2000) 0.77
Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing. J Immunol (1995) 0.77
Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization. J Immunol (1998) 0.77
Localization of a novel natural killer triggering receptor locus to human chromosome 3p23-p21 and mouse chromosome 9. Genomics (1993) 0.77
Amelioration of experimental lung metastasis in mice by therapy with anti-CD3 monoclonal antibodies. Cancer Immunol Immunother (1989) 0.77
A functional and phenotypic comparison of murine natural killer (NK) cells and lymphokine-activated killer (LAK) cells. Int J Cancer (1989) 0.77
Association of the expression of an SR-cyclophilin with myeloid cell differentiation. Blood (1996) 0.77
IL-2 regulates the expression of the NK-TR gene via an alternate RNA splicing mechanism. Mol Immunol (1993) 0.77
Pain relief after day case laparoscopy. Anaesthesia (1992) 0.75
Prescribing of opioid analgesia. Anaesthesia (1998) 0.75
Optimum LMA cuff pressure. Anaesthesia (1996) 0.75
Peri-operative management of diabetes. Anaesthesia (2007) 0.75
Pre-operative hypertension--true or false? Anaesthesia (1997) 0.75
Modification of Goldman dental mask. Anaesthesia (1988) 0.75
Meningitis following spinal anaesthesia. Anaesthesia (1991) 0.75
Blood transfusion and colorectal cancer. Br Med J (Clin Res Ed) (1985) 0.75
Use of heparin in arterial lines. Anaesthesia (1998) 0.75
False elevation of serum thyroxine in myxoedema due to thyroxine-binding autoantibodies. A diagnostic pitfall. Ulster Med J (1986) 0.75
Pre-operative information about anaesthesia--is more better? Anaesthesia (2003) 0.75
A controlled study of lymphocyte subsets in rheumatoid arthritis. Clin Immunol Immunopathol (1992) 0.75
Relationship of pain behavior to disease activity and health status in rheumatoid arthritis. Arthritis Care Res (1993) 0.75